Home › NDC Lookup › RxCUI directory › RxCUI 2696887

{24 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Disintegrating Oral Tablet) /... — RxCUI 2696887

RxNorm drug concept · Generic pack
RxCUI 2696887 Generic pack · GPCK ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2696887
Official name{24 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Disintegrating Oral Tablet) / 4 (inert ingredients 1 MG Disintegrating Oral Tablet) } Pack
Concept typeGeneric pack (GPCK)
RxNorm statusCurrent RxNorm concept
Also known asethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Disintegrating Oral Tablet 28 Day Pack
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)1,031 prescriptions · 10 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Norethindrone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Most norethindrone products, like Errin, Camila and Emzahh, are progestin-only birth control pills that prevent pregnancy. Norethindrone acetate tablets, such as Gallifrey, are use...
  • Take one tablet by mouth every day at the same time. Don't take a break between packs. Following the schedule exactly gives you the best protection, so follow your label and the pa...
  • Changes in your bleeding are the most common, including irregular or frequent bleeding. Some people get headache, breast tenderness, nausea or dizziness. Call me or your doctor if...
  • It's best not to. Smoking greatly raises the risk of heart attack and stroke in women using oral contraceptives. If you smoke, let's talk about options and quitting.
📖 Read our full Norethindrone guide →

🕸️ Concept Web — How {24 (ethinyl estradiol 0.02 MG / norethindrone a... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept {24 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Disintegrating Oral Tablet) / 4 (inert ingredients 1 MG Disintegrating Oral Tablet) } Pack RxCUI 2696887

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 5

    The active substance itself — no strength, form, or brand attached yet.

    • Ethinyl estradiol 4124
    • Inert ingredients 748794
    • Norethindrone 7514
    • Ethinyl estradiol / norethindrone 384410
    • Norethindrone acetate 31983
  2. Dose forms 16

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ethinyl estradiol / norethindrone Disintegrating Oral Tablet 2696880
    • Inert ingredients Disintegrating Oral Tablet 2696885
    • Ethinyl estradiol / norethindrone acetate Disintegrating Oral Tablet 2696882
    • Ethinyl estradiol / norethindrone Disintegrating Oral Product 2696879
    • Ethinyl estradiol / norethindrone Oral Product 1157354
    • Ethinyl estradiol / norethindrone Pill 1157355
    • Inert ingredients Disintegrating Oral Product 2696884
    • Inert ingredients Oral Product 1156911
    • +8 more in this family
  3. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  4. Packs 1

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 19 of 27 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Disintegrating Oral Tablet SCD · 2696883
  • Inert ingredients 1 MG Disintegrating Oral Tablet SCD · 2696886
  • Ethinyl estradiol 0.02 MG SCDC · 317366
  • Inert ingredients 1 MG SCDC · 748795
  • Norethindrone acetate 1 MG SCDC · 1037182
  • Ethinyl estradiol / norethindrone Disintegrating Oral Tablet SCDF · 2696880
  • Inert ingredients Disintegrating Oral Tablet SCDF · 2696885
  • Ethinyl estradiol / norethindrone acetate Disintegrating Oral Tablet SCDFP · 2696882
  • Ethinyl estradiol / norethindrone Disintegrating Oral Product SCDG · 2696879
  • Ethinyl estradiol / norethindrone Oral Product SCDG · 1157354

Brand-Name Concepts

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 2696887 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
72495-0601-28 1 POUCH in 1 CARTON (72495-601-28) / 1 BLISTER PACK in 1 PO... FEMLYV Millicent US, Inc. 2024-11-01
72495-0601-84 3 POUCH in 1 CARTON (72495-601-84) / 1 BLISTER PACK in 1 PO... FEMLYV Millicent US, Inc. 2024-11-01
Observed labelers: Millicent US, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.